Harry Glorikian of TSG-Partners on PCR s IP Pitfalls | GenomeWeb

Harry Glorikian is a principle partner of TSG-Partners, a life-sciences strategic consultancy, and a former senior manager at Applied Biosystems, with responsibilities in new technology assessment, business development, and product and sales management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.